New research led by Dr Elizabeth Goodall reveals a striking gap between clinical trial recruitment criteria and real-world cancer patients
➡️ Read the British Journal of Haematology paper: https://onlinelibrary.wiley.com/doi/10.1111/bjh.70550
#LymphomaResearch #CancerResearch #ClinicalTrials
ONJ Cancer Research Institute
🎉 Congratulations to PhD student Birhanu Ayelign for receiving an Abacus Dx 2026 Emerging Investigators Grant to advance his phage therapy research in gastric cancer.
#gastriccancer #phagetherapy
🎉 Congratulations to postdoctoral researcher Dr Pavitha Parathan for becoming the first-ever recipient of Pancare Foundation's Eliza Wilmot Scholarship.
➡️ Read more: https://ow.ly/zJ0150Z1rF2
A new review paper by ONJCRI researchers Anamika Saini and Dr Shiyao Li investigates how the biomolecular corona that forms on RNA-lipid nanoparticles shapes their cargo delivery behaviour.
➡️ ow.ly/mOhR50Z5rpA (ACS Nano @pubs.acs.org)
#LipidNanoparticles #Nanomedicine
Congratulations to Prof Eliza Hawkes, her team and collaborators who received a $1.9m Cancer Australia grant to activate the iLIMM lymphoma study. Objectives:
• Advanced tumour and immune system mapping
• Testing whether physical exercise could improve outcomes
➡️ https://ow.ly/a8KN50YVmKN
#NHMRC
Congratulations to Kaitlyn Kew on receiving a Tour de Cure PhD Scholarship đź‘Ź
Her research is on children with B-cell acute lymphoblastic leukaemia (B-ALL). With ~10% of patients experiencing relapse, this work could help drive more effective treatments.
#CancerResearch #PhD #Leukaemia
Congratulations to our researchers who were awarded funding from Tour de Cure to pursue innovative and impactful cancer research projects.
• Dr Bhupinder Pal
• Dr Zhipeng Cao
• Dr Rebekah Crake
➡️ Read more: https://ow.ly/HARX50YKLUi
#CancerResearch #ResearchFunding
Global cancer care faces a 100 million worker shortfall by 2050, suggests new Commission report. With coordinated investment:
đź“Ś 170 million deaths prevented
đź“Ś $120 trillion net economic benefit
Prof Andrew Scott was a Commission co-author.
Read more in The Lancet Oncology: tinyurl.com/ysa9zv37
We are delighted to share that our 2025 Annual Report is now published and available to read ➡️️ https://ow.ly/4nWW50Z4xVA
#CancerResearch #AnnualReport
Results from ONJCRI’s MoST-CIRCUIT clinical trial suggest that combination immunotherapy with nivolumab and ipilimumab is a promising avenue for hard-to-treat gallbladder cancer patients.
➡️ https://ow.ly/RLX450YT3pI
#ClinicalTrials #GallbladderCancer #BiliaryTractCancer #immunotherapy
